Ascendis Pharma A/S Other Current Receivables
Ascendis Pharma A/S (ASND) had Other Current Receivables of EUR 14.58 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes › Receivables
ifrs-full:OtherCurrentReceivables · last filed 2026-02-11
- 2025-12-31: Other Current Receivables 14.58M EUR.
- 2025-09-30: Other Current Receivables 9.58M EUR.
- 2025-06-30: Other Current Receivables 8.03M EUR.
- 2025-03-31: Other Current Receivables 8.52M EUR.
| Period end | Other Current Receivables | Other Current Receivables as first filed |
|---|---|---|
| 2025-12-31 | 14.58M EUR 20-F · filed 2026-02-11 | |
| 2025-09-30 | 9.58M EUR 6-K · filed 2025-11-12 | |
| 2025-06-30 | 8.03M EUR 6-K · filed 2025-08-07 | |
| 2025-03-31 | 8.52M EUR 6-K · filed 2025-05-01 | |
| 2024-12-31 | 9.38M EUR 20-F · filed 2026-02-11 | |
| 2024-09-30 | 15.26M EUR 6-K · filed 2024-11-14 | |
| 2024-06-30 | 29.68M EUR 6-K · filed 2024-09-03 | |
| 2024-03-31 | 26.86M EUR 6-K · filed 2024-05-02 | |
| 2023-12-31 | 19.10M EUR 20-F · filed 2025-02-12 | |
| 2023-09-30 | 21.59M EUR 6-K · filed 2023-11-07 | |
| 2023-06-30 | 14.13M EUR 6-K · filed 2023-09-05 | |
| 2023-03-31 | 17.38M EUR 6-K · filed 2023-04-27 | |
| 2023-01-01 | 12.83M EUR 20-F · filed 2025-02-12 | |
| 2022-12-31 | 12.83M EUR 20-F · filed 2024-02-07 | |
| 2022-09-30 | 13.26M EUR 6-K · filed 2022-11-02 | |
| 2022-06-30 | 15.05M EUR 6-K · filed 2022-08-10 | |
| 2022-03-31 | 15.07M EUR 6-K · filed 2022-05-11 | |
| 2021-12-31 | 20.09M EUR 20-F · filed 2023-02-16 | |
| 2021-09-30 | 20.26M EUR 6-K · filed 2021-11-10 | |
| 2021-06-30 | 11.40M EUR 6-K · filed 2021-08-27 | |
| 2021-03-31 | 7.18M EUR 6-K · filed 2021-05-27 | |
| 2020-12-31 | 6.96M EUR 20-F · filed 2022-03-02 | |
| 2020-09-30 | 4.51M EUR 6-K · filed 2020-11-12 | |
| 2020-06-30 | 5.33M EUR 6-K · filed 2020-08-27 | |
| 2020-03-31 | 4.78M EUR 6-K · filed 2020-05-19 | |
| 2019-12-31 | 4.61M EUR 20-F · filed 2021-03-10 | 3.14M EUR 20-F · filed 2020-04-03 |
| 2019-09-30 | 1.75M EUR 6-K · filed 2019-11-18 | |
| 2019-06-30 | 1.45M EUR 6-K · filed 2019-08-28 | |
| 2019-03-31 | 6.86M EUR 6-K · filed 2019-05-30 | |
| 2018-12-31 | 1.77M EUR 20-F · filed 2020-04-03 | |
| 2018-09-30 | 2.75M EUR 6-K · filed 2018-11-28 | |
| 2018-06-30 | 1.83M EUR 6-K · filed 2018-08-29 | |
| 2018-03-31 | 1.13M EUR 6-K · filed 2018-05-30 | |
| 2017-12-31 | 1.41M EUR 20-F · filed 2019-04-03 | |
| 2016-12-31 | 640.00K EUR 20-F · filed 2018-03-28 |